IL206720A0 - Antigen-binding polypeptides against cartilage degeneration - Google Patents

Antigen-binding polypeptides against cartilage degeneration

Info

Publication number
IL206720A0
IL206720A0 IL206720A IL20672010A IL206720A0 IL 206720 A0 IL206720 A0 IL 206720A0 IL 206720 A IL206720 A IL 206720A IL 20672010 A IL20672010 A IL 20672010A IL 206720 A0 IL206720 A0 IL 206720A0
Authority
IL
Israel
Prior art keywords
antigen
binding polypeptides
cartilage degeneration
polypeptides against
against cartilage
Prior art date
Application number
IL206720A
Other languages
English (en)
Original Assignee
Delenex Therapeutics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delenex Therapeutics Ag filed Critical Delenex Therapeutics Ag
Publication of IL206720A0 publication Critical patent/IL206720A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL206720A 2008-02-05 2010-06-30 Antigen-binding polypeptides against cartilage degeneration IL206720A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2631708P 2008-02-05 2008-02-05
US8887608P 2008-08-14 2008-08-14
PCT/CH2009/000045 WO2009097704A1 (en) 2008-02-05 2009-02-05 Antigen-binding polypeptides against cartilage degeneration

Publications (1)

Publication Number Publication Date
IL206720A0 true IL206720A0 (en) 2010-12-30

Family

ID=40568129

Family Applications (1)

Application Number Title Priority Date Filing Date
IL206720A IL206720A0 (en) 2008-02-05 2010-06-30 Antigen-binding polypeptides against cartilage degeneration

Country Status (10)

Country Link
US (1) US20110002927A1 (cg-RX-API-DMAC10.html)
EP (1) EP2240515A1 (cg-RX-API-DMAC10.html)
JP (1) JP2011510667A (cg-RX-API-DMAC10.html)
CN (1) CN101939335B (cg-RX-API-DMAC10.html)
AU (1) AU2009212079B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0907485A2 (cg-RX-API-DMAC10.html)
CA (1) CA2712965A1 (cg-RX-API-DMAC10.html)
IL (1) IL206720A0 (cg-RX-API-DMAC10.html)
RU (1) RU2010136988A (cg-RX-API-DMAC10.html)
WO (1) WO2009097704A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012040623A2 (en) 2010-09-24 2012-03-29 The Brigham And Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
CN104231086B (zh) * 2013-08-27 2019-12-13 北京韩美药品有限公司 双功能融合蛋白及其制备方法和用途
US10143762B2 (en) 2013-12-13 2018-12-04 Mercury Assel Management Co., Ltd. Articular cartilage imaging composition
EP3452094B1 (en) * 2016-05-06 2021-11-17 The Brigham and Women's Hospital, Inc. Binary self assembled gels for controlled delivery of encapsulated agents to cartilage
CN113825495A (zh) 2018-10-11 2021-12-21 阿利维奥治疗学股份有限公司 用于智能释放的不可注射水凝胶调配物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0013810D0 (en) * 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
EP1891110A2 (en) * 2005-06-07 2008-02-27 Esbatech AG STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF-alpha
ES2603399T3 (es) * 2006-07-10 2017-02-27 Esbatech, An Alcon Biomedical Research Unit Llc Anticuerpos scFv que atraviesan capas epiteliales y/o endoteliales

Also Published As

Publication number Publication date
AU2009212079A1 (en) 2009-08-13
RU2010136988A (ru) 2012-03-20
CA2712965A1 (en) 2009-08-13
EP2240515A1 (en) 2010-10-20
US20110002927A1 (en) 2011-01-06
JP2011510667A (ja) 2011-04-07
CN101939335B (zh) 2015-02-11
BRPI0907485A2 (pt) 2015-08-04
WO2009097704A1 (en) 2009-08-13
AU2009212079B2 (en) 2012-08-30
CN101939335A (zh) 2011-01-05

Similar Documents

Publication Publication Date Title
GB2457110B (en) Sifting containers
EP2274687A4 (en) ASSESSMENTS USING A MACHINE READABLE REPRESENTATION
GB0804178D0 (en) Moving mirror
ZA201003850B (en) Antigen-binding constructs
GB0821100D0 (en) Antibodies
ZA201006099B (en) Anti-tyrp1 antibodies
PL2254769T3 (pl) Okucie
AP00230S1 (en) Container
GB0902610D0 (en) Materials
GB0817677D0 (en) construction materials
ZA201007976B (en) Anti-pirb antibodies
GB2476226B (en) Optimisation
GB0816976D0 (en) Protein
PL2379978T3 (pl) Dystrybutor płynów z symetrią obrotową
GB0818356D0 (en) Antibodies
BRPI0907485A2 (pt) Polipeptídeos de ligação a antígeno contra degeneração de cartilagem
GB0809659D0 (en) Polypeptides
GB0911770D0 (en) Antibody
HK1149027A (en) Antigen-binding polypeptides against cartilage degeneration
GB0818627D0 (en) Protein
GB0814373D0 (en) Tissue-adhesive materials
GB0812733D0 (en) Self-coalescing materials
GB0817077D0 (en) Proteins
PL2149351T3 (pl) Komponent endoprotezy
IL195369A0 (en) Sell college